Amgen Inc. (AMGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
208.99-0.67 (-0.32%)
At close: 4:00PM EDT
209.09 +0.10 (+0.05%)
Pre-market: 07:58AM EDT
Pre-market: 07:58AM EDT
| Previous close | 209.66 |
| Open | 210.15 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 1000 |
| Day's range | 207.67 - 210.26 |
| 52-week range | 200.47 - 276.69 |
| Volume | 1,921,075 |
| Avg. volume | 2,539,547 |
| Market cap | 118.675B |
| Beta (5Y monthly) | 0.68 |
| PE ratio (TTM) | 21.20 |
| EPS (TTM) | 9.86 |
| Earnings date | 02 Nov 2021 |
| Forward dividend & yield | 7.04 (3.37%) |
| Ex-dividend date | 16 Aug 2021 |
| 1y target est | 247.45 |
- Zacks
Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, Amgen (AMGN) closed at $206.78, marking a +1.8% move from the previous day.
- Motley Fool
2 Best Biotech Stocks to Buy Right Now
These dividend stocks provide sustainable and growing dividends, which are nearly triple the S&P 500's yield.
- Zacks
Amgen (AMGN) Reports New Data From Lumakras Combo Study
Amgen (AMGN) reports new combination data from the phase Ib CodeBreaK 101 study. It also buys a stake in Neumora Therapeutics to advance novel therapies for brain diseases.
© 2021 Verizon Media. All rights reserved.
